{"nct_id":"NCT05599984","title":"Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-12-05","start_date_type":"ACTUAL","primary_completion_date":"2026-06","primary_completion_date_type":"ESTIMATED","completion_date":"2026-06","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["ABBV"]}